StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
BIOX$0.48+7.67%
Fair $0.48+0.0%

BIOX

Bioceres Crop Solutions Corp.

Basic Materials / Agricultural InputsNasdaqGS

$0.48

+0.03 (+7.67%)

Fairly Valued+0.0%Fair Value $0.48Fund rank 28/100 · Data gapFallback financials|
SA 20/D
F-Score: 2/9
Margin CompressionLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $18.9M · quality 45.3/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 27/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

20/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. Operating margin has declined for 3 consecutive years ROE is -21.1%, below the 5% threshold
Thesis & Journal · BIOXLocal privado en este navegador · Bioceres Crop Solutions Corp.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$31M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-21.1%

↓

Gross Margin

38.4%

↑

Debt/Equity

1.05

↑
52-Week Range$0
$0$5

TradingView lightweight chart

BIOX price, volumen y niveles de valoración

Último $0.480Periodo -95.0%
Fair value: $0.480

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+0.5%

FCF CAGR

—

FCF margin

10.6%

FCF / Net income

-0.64x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $333.3M · net income $-55.4M · FCF $35.3M

2022-FY → 2025-FY

Gross margin

38.4%+0.5% pts

Operating margin

-0.2%-13.7% pts

Net margin

-16.6%-14.4% pts

FCF margin

10.6%+18.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$333.3M$333.3M$464.8M$419.4M$328.5M
Net Income$-55.4M$-55.4M$4.3M$18.8M$-7.2M
EBITDA$-9.8M$-9.8M$56.5M$59.7M$38.2M
EPS-0.88-0.880.050.30-0.17
Gross Margin38.4%38.4%39.2%42.6%38.0%
Operating Margin-0.2%-0.2%9.5%12.7%13.5%
Net Margin-16.6%-16.6%0.9%4.5%-2.2%
Balance Sheet
Debt/Equity1.051.050.860.861.33
Current Ratio0.880.88———
Cash Flow
Free Cash Flow$35.3M$35.3M$18.9M$-20.0M$-26.5M
Returns
ROE-21.1%-21.1%1.4%6.3%-5.6%
Valuation
P/E——219.1844.25—
EV/EBITDA——16.6017.4217.70
P/B0.120.122.262.784.23
Growth & Yield
Revenue Growth-28.3%-28.3%10.8%27.7%—
EPS Growth-1815.1%-1815.1%-82.8%274.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -90.2%

Total return

-90.2%

Start / end P/E

n/dx → n/dx

EPS bridge

0.05 → -0.88

Residual

-90.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-90.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.